在口腔状细胞癌的环境中,CRISPR技术的最新进展
Anirban Goutam Mukherjee1, Kaviyarasi R1, Abilash Valsala Gopalakrishnan1
1Department of Biomedical Sciences, School of Bio-Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
Pathology, research and practice
|March 2, 2025
概括
克里斯普尔/卡斯技术为口腔状细胞癌 (OSCC) 研究提供了精确的基因编辑. 本信件探讨了应用CRISPR/Cas工具来理解和潜在地治疗OSCC的最新进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 口腔状细胞癌 (OSCC) 占口腔癌的90%以上,存活率有所改善,但潜在的机制仍在研究中.
- 目前的放射和化疗等治疗方法都有局限性和副作用,这凸显了对新型治疗策略的需求.
- 克里斯普尔/卡斯技术已经成为精确基因编辑的强大工具,为生物研究和治疗开发提供了新的途径.
研究的目的:
- 在口腔状细胞癌 (OSCC) 的背景下,审查CRISPR/Cas技术应用的最新进展.
- 突出CRISPR/Cas技术在应对与OSCC研究和治疗开发相关的挑战方面的潜力.
主要方法:
- 本信件讨论了CRISPR/Cas技术在OSCC研究中的最新发现和应用.
- 专注于基因编辑工具的实用性,以了解OSCC分子过程.
主要成果:
- 在OSCC研究中,CRISPR/Cas技术显示出精确基因操纵的巨大潜力.
- 克里斯普尔/卡斯的应用正在推进对OSCC分子基础和潜在治疗点的理解.
结论:
- 克里斯普尔/卡斯技术有望改善口腔状细胞癌的研究和治疗.
- 进一步探索CRISPR/Cas应用对于开发更有效的OSCC疗法至关重要.
更多相关视频
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
7.8K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.4K
相关概念视频
CRISPR
48.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
48.9K
Homologous Recombination
50.0K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.0K
CRISPR and crRNAs
16.5K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
